Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Divis Laboratories Ltd - 532488 - Outcome Of Board Meeting Held On 05 February, 2020

 We would like to inform that the Board of Directors of the Company at its meeting held on 05 February, 2020 has, inter alia, approved the Unaudited Financial Results for the quarter and nine months ended 31 December, 2019. The Board also noted that the Company has commenced commercial operations effective from 05 February, 2020 from a part of the DC-SEZ Unit at village Lingojigudem, Choutuppal Mandal, Bhuvangiri Yadadri Dist., Telangana.
05-02-2020
Bigul

Divis Laboratories Ltd - 532488 - Unaudited Financial Results For The Quarter And Nine Months Ended 31 December, 2019

 We would like to inform that the Board of Directors of the Company at its meeting held on 05 February, 2020 has, inter alia, approved the Unaudited Financial Results for the quarter and nine months ended 31 December, 2019. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the following: 1.Unaudited Standalone Financial Results for the quarter and nine months ended 31 December, 2019 along with Limited Review Report of the Statutory Auditors thereon. 2.Unaudited Consolidated Financial Results for quarter and nine months ended 31 December, 2019 along with Limited Review Report of the Statutory Auditors thereon. 3.Press Release on the said Financial Results of the Company and other information. The Board also noted that the Company has commenced commercial operations effective from 05 February, 2020 from a part of the DC-SEZ Unit at village Lingojigudem, Choutuppal Mandal, Bhuvangiri Yadadri Dist., Telangana.
05-02-2020

Divis Labs share price gains 2% after no USFDA observations for Chippada unit

 The company's Unit-II in Andhra Pradesh inspected by the US Food and Drug Administration in the last week on January.
01-02-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - US-FDA Inspection Of Unit -II At Village Chippada, Andhra Pradesh

 This is to inform that the Company's Unit-II at Village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the US Food and Drug Administration (US-FDA) from 27 January, 2020 to 31 January, 2020. The inspection has been concluded with no '483'observations. This is for your information and records.
31-01-2020
Bigul

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper advertisement confirming despatch of Postal Ballot Notice dated 04 January, 2020 and giving details of e-voting
28-01-2020
Bigul

Divis Laboratories Ltd - 532488 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Intimation of Postal Ballot Notice dated 04 January, 2020
27-01-2020
Bigul

Divis Laboratories Ltd - 532488 - Board Meeting Intimation for Considering And Approving Standalone And Consolidated Un-Audited Financial Results For The Quarter And Nine Months Ended 31 December, 2019.

 DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2020 ,inter alia, to consider and approve Standalone and Consolidated un-audited Financial Results for the quarter and nine months ended 31 December, 2019.
21-01-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from KFin Technologies Private Limited (formerly known as Karvy Fintech Private Limited), Registrar & Share Transfer Agent of the Company dated 14 January, 2020 for the quarter ended 31 December, 2019. This is for your information and records.
20-01-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Shareholding for the Period Ended December 31, 2019

 Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
06-01-2020
Bigul

Divis Laboratories Ltd - 532488 - Statement Of Investor Complaints For The Quarter Ended December 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- M Satish ChoudhuryDesignation :- Company Secretary and Compliance Officer
06-01-2020
Next Page
Close

Let's Open Free Demat Account